Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.1.219NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.219NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.219NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
N.8NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-1575.86US
N.8NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
N.8NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-2066.7China
XANUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XANYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XANChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
AZ.4NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
AZ.4NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AZ.4NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.114NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.114NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.114NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.177.39NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.177.39NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.177.39NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.199NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.199NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.199NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.190NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.190NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.190NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.552NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.552NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.552NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
C.5NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
C.5NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
C.5NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
AF.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
AF.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AF.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.177.89NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.177.89NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.177.89NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
M.2NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
M.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
M.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.333NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.333NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.333NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.429NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.429NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.429NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.463NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.463NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.463NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
U.3NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
U.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used